Production (Stage)
Evolent Health, Inc.
EVH
$7.21
-$0.15-2.04%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -108.96M | -61.62M | -72.23M | -74.42M | -110.34M |
| Total Depreciation and Amortization | 132.22M | 137.66M | 92.78M | 95.18M | 97.34M |
| Total Amortization of Deferred Charges | 34.25M | 33.95M | 35.99M | 37.45M | 39.94M |
| Total Other Non-Cash Items | 118.63M | 81.79M | 89.49M | 98.21M | 103.62M |
| Change in Net Operating Assets | -101.26M | -116.56M | -11.65M | 19.81M | 24.89M |
| Cash from Operations | 18.42M | 18.77M | 134.38M | 176.23M | 155.47M |
| Capital Expenditure | -39.48M | -33.12M | -41.74M | -31.25M | -26.42M |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 577.00K | 577.00K |
| Cash Acquisitions | -19.50M | -19.50M | 0.00 | 0.00 | -1.52M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.31M | -10.31M | -7.31M | -4.80M | -2.92M |
| Cash from Investing | -66.29M | -62.93M | -49.05M | -35.47M | -30.28M |
| Total Debt Issued | 279.58M | 58.58M | 391.43M | 391.43M | 391.16M |
| Total Debt Repaid | -61.97M | 0.00 | -417.23M | -427.23M | -427.23M |
| Issuance of Common Stock | 2.40M | 3.46M | 6.80M | 8.98M | 12.00M |
| Repurchase of Common Stock | -5.96M | -15.70M | -16.33M | -17.25M | -17.02M |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -19.58M | -20.09M | -20.44M | -20.40M | -20.22M |
| Other Financing Activities | -102.06M | -26.82M | -126.08M | -145.76M | -22.20M |
| Cash from Financing | 92.41M | -565.00K | -181.86M | -210.22M | -83.51M |
| Foreign Exchange rate Adjustments | -168.00K | -229.00K | -111.00K | -190.00K | -167.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.37M | -44.96M | -96.65M | -69.65M | 41.51M |